CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation
Clinical trial NCT03911193 · UNKNOWN
Trial details
- NCT number
- NCT03911193
- Sponsor
- Fondazione Ricerca Traslazionale
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2020-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.